Search Results

The MyAllergyTest® is for the collection and transport of a capillary blood sample to a clinical laboratory for allergen specific IgE profile testing. The MyAllergyTest® is intended for use with the MyAllergyTest® system. The MyAllergyTest® is intended for home use.

MyAllergyTest ® is a Sample Collection Kit containing the materials necessary to collect and mail a capillary blood sample to a clinical laboratory for allergen specific IgE profile testing. The device modification is to revise the limitations statement to allow testing of the whole blood sample for up to 30 days following collection. Currently the limitations states 10 days. No changes to the kit components.

The provided document describes a 510(k) premarket notification for a modification to the MyAllergyTest® device. The modification is to extend the allowable time for a whole blood sample to be tested from 10 days to 30 days after collection.

Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

1. A table of acceptance criteria and the reported device performance

Note: The document does not explicitly state numerical acceptance criteria (e.g., specific percentage agreement or correlation thresholds). The acceptance criterion is implied by the need to ensure an "accurate assessment" of IgE levels after 30 days.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not specify the sample size used for the stability studies (test set). It also doesn't indicate the country of origin of the data or whether the study was retrospective or prospective.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not provided. The study appears to be about sample stability for laboratory testing, not interpretation by human experts. The "ground truth" would likely be established by lab-based assay results, not expert consensus in the traditional sense.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable as the study involves laboratory measurements for sample stability, not expert interpretation requiring adjudication.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable. The device is a sample collection kit, and the study focuses on the stability of the collected sample, not on human reader performance or AI assistance.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

This is not applicable. The device is a physical sample collection kit, and the study evaluates the bio-chemical stability of the collected sample, not an algorithm's standalone performance.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The ground truth for the stability studies would be the allergen specific IgE profile testing results obtained from the clinical laboratory at different time points (including 30 days) and compared against a baseline (e.g., immediate testing). The "accuracy" would be determined by comparing these results, likely through quantitative measures of IgE levels.

8. The sample size for the training set

This is not applicable. The study is a validation of sample stability, not a machine learning model that requires a training set.

9. How the ground truth for the training set was established

This is not applicable, as there is no training set for this type of device modification study.

Summary of the Study:

The study described is a "Blood Sample Stability Study." Its purpose was to "obtain assurance that the whole blood sample would still provide an accurate assessment of allergen specific IgE for the entire transport time indicated in the labeling (30 days)." The study involved "Initial testing and validation results," which "confirmed that the sample would be stable during the indicated transport time." This implies a comparison of IgE levels from samples tested at baseline and after 30 days to ensure they remain consistent or within an acceptable variation range, thereby maintaining the accuracy of the overall allergen-specific IgE assessment. The specific methodologies and statistical analysis are not detailed in this document but are referred to in "Attachment (s) B and C."

Ask a specific question about this device

The MyAllergyTest™ is for the collection and transport of a capillary blood sample to a clinical laboratory for allergen specific IgE profile testing. The MyAllergyTest™ is intended for use with the MyAllergyTest™ System. The MyAllergyTest™ is intended for home use by the lay consumer (Over-the-Counter).

MyAllergyTest™ is a Sample Collection Kit containing the materials necessary to collect and mail a capillary blood sample to a clinical laboratory for allergen specific IgE profile testing.

The provided text describes the MyAllergyTest™ and its 510(k) submission, primarily focusing on its intended use as a blood sample collection kit for home use. The studies performed are to demonstrate the kit's functionality and consumer usability, not the diagnostic performance of an AI algorithm. Therefore, many of the requested fields related to AI performance metrics, ground truth, and expert evaluation are not applicable to this device.

Here's a breakdown of the available information:

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

The text does not specify the sample sizes used for any of the studies (Stability, Mailing, Consumer, Consumer Comprehension, Readability). It also does not mention the country of origin of the data or whether the studies were retrospective or prospective.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

This is not applicable as the device is a sample collection kit, not an AI diagnostic tool. The "ground truth" for the studies listed is related to the physical stability of blood samples, the ability of lay users to follow instructions, and the readability of documentation, not expert interpretation of medical images or data.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable. This concept is relevant for reconciling discrepancies in expert ground truth assessment, which is not part of the described studies for this device.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. The MyAllergyTest™ is a sample collection kit, not an AI system or software with a human-in-the-loop component.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable. The MyAllergyTest™ is a physical medical device (sample collection kit), not an algorithm or AI.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The "ground truth" for these studies would be defined by objective measurements based on the study type:

• Stability Studies & Mailing Studies: The "ground truth" would be the actual concentration or integrity of allergen-specific IgE markers in the blood samples after various transport conditions and durations, as measured by a clinical laboratory.
• Consumer Studies: The "ground truth" would be the successful collection of a blood sample by the lay consumer, verified objectively (e.g., by the presence of a viable sample).
• Consumer Comprehension Studies: The "ground truth" would be the ability of lay consumers to correctly answer questions or demonstrate understanding of the package insert.
• Readability Studies: The "ground truth" would be the calculated reading level of the package insert using the SMOG Readability Formula.

8. The sample size for the training set

Not applicable. This device is not an AI algorithm, so there is no "training set."

9. How the ground truth for the training set was established

Not applicable. There is no training set for this device.

Ask a specific question about this device